CHRS Operating Income
Coherus Oncology Inc · Operating Income
CHRS Operating Income
Latest reported-$156.60Mperiod ending
CHRS Operating Income (-$38.52M → -$156.60M)
Annual operating income
High-resolution chart · PNG
CHRS operating income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -179,534,000 | |
| -111,667,000 | |
| -203,199,000 | |
| -256,880,000 | |
| -263,858,000 | |
| 156,319,000 | |
| 107,768,000 | |
| -204,416,000 | |
| -232,136,000 | |
| -115,931,000 | |
| -219,067,000 | |
| -64,682,000 | |
| -35,993,000 | |
| -38,518,000 |